We are live on ! Find out more
PD

Point72 (DIFC) Portfolio holdings

AUM $1.53B
1-Year Est. Return 15.83%
This Fund
S&P 500
This Quarter Est. Return
+4.78%
1 Year Est. Return
+15.83%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$1.53B
AUM Growth
-$1.12B
Cap. Flow
-$1.18B
Cap. Flow %
-77.26%
Top 10 Hldgs %
24.76%
Holding
1,997
New
503
Increased
228
Reduced
373
Closed
880

Top Buys

Rank Stock Value
1
META icon
Meta Platforms (Facebook)
META
+$44.7M
2
MSFT icon
Microsoft
MSFT
+$41.9M
3
BSX icon
Boston Scientific
BSX
+$27.2M
4
V icon
Visa
V
+$26.6M
5
TSM icon
TSMC
TSM
+$25.3M

Top Sells

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$30.4M
2
ADI icon
Analog Devices
ADI
+$24.4M
3
TMO icon
Thermo Fisher Scientific
TMO
+$24.4M
4
GE icon
GE Aerospace
GE
+$22.9M
5
LRCX icon
Lam Research
LRCX
+$21.2M

Sector Composition

Rank Sector Weight
1 Healthcare 25.12%
2 Technology 23.11%
3 Financials 13.26%
4 Communication Services 8.27%
5 Consumer Discretionary 7.57%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MGX icon
1101
Metagenomi Therapeutics
MGX
$45.6M
$318 ﹤0.01%
134
BAER icon
1102
Bridger Aerospace
BAER
$112M
$315 ﹤0.01%
+170
New +$322
OVID icon
1103
Ovid Therapeutics
OVID
$440M
$256 ﹤0.01%
197
-1,104
-85% -$957
MRAM icon
1104
Everspin Technologies
MRAM
$328M
$223 ﹤0.01%
24
-1,076
-98% -$7.31K
FFIC
1105
DELISTED
Flushing Financial
FFIC
$215 ﹤0.01%
+16
New +$208
PLRX icon
1106
Pliant Therapeutics
PLRX
$66.3M
$166 ﹤0.01%
112
-6,996
-98% -$10.7K
KLAR
1107
Klarna Group
KLAR
$7.07B
$156 ﹤0.01%
+4
New +$171
IRBT
1108
DELISTED
iRobot
IRBT
$101 ﹤0.01%
28
-3,933
-99% -$15.2K
NMRA icon
1109
Neumora Therapeutics
NMRA
$311M
$93 ﹤0.01%
51
-1,068
-95% -$1.73K
SCWO icon
1110
374Water
SCWO
$38.7M
$87 ﹤0.01%
30
MERC icon
1111
Mercer International
MERC
$45.6M
$86 ﹤0.01%
30
CRBU icon
1112
Caribou Biosciences
CRBU
$148M
$77 ﹤0.01%
33
-5,202
-99% -$9.82K
ATOS icon
1113
Atossa Therapeutics
ATOS
$24.1M
$71 ﹤0.01%
5
-552
-99% -$6.82K
DDL
1114
Dingdong
DDL
$527M
$43 ﹤0.01%
21
-2,879
-99% -$6.24K
DC icon
1115
Dakota Gold
DC
$629M
$36 ﹤0.01%
8
+2
+33% +$8
LXRX icon
1116
Lexicon Pharmaceuticals
LXRX
$1.04B
$20 ﹤0.01%
15
-6,967
-100% -$7.91K
INFU icon
1117
InfuSystem Holdings
INFU
$200M
$10 ﹤0.01%
1
-1,299
-100% -$10.8K
A icon
1118
CALL
Agilent Technologies
A
$39.7B
-400
Closed -$47.2K
A icon
1119
PUT
Agilent Technologies
A
$39.7B
-200
Closed -$23.6K
ABM icon
1120
ABM Industries
ABM
$2.88B
-1,146
Closed -$54.1K
ACAD icon
1121
Acadia Pharmaceuticals
ACAD
$4.45B
-9,764
Closed -$211K
ACEL icon
1122
Accel Entertainment
ACEL
$1.01B
-1,088
Closed -$12.8K
ACI icon
1123
Albertsons Companies
ACI
$5.67B
-195,335
Closed -$4.2M
ACMR icon
1124
ACM Research
ACMR
$4.98B
-1,007
Closed -$26.1K
ADBE icon
1125
CALL
Adobe
ADBE
$99B
-2,100
Closed -$812K

Similar funds

Point72 (DIFC)'s Q3 2025 Portfolio in Review

As of Q3 2025, Point72 (DIFC) held 1,997 positions worth $1.53B, down 42% from $2.64B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Point72 (DIFC) withdrew a net $1.18B in Q3 2025, closing 880 positions and reducing 373 holdings. Its most notable exit was NVIDIA, an estimated $30.4M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 25% of assets, up from 14% a quarter earlier, followed by Technology and Financials.

Against the trend, Point72 (DIFC) opened a new position in Visa worth $26.2M.

  • Point72 (DIFC)'s largest Q3 2025 buy was Visa: 76,800 shares worth $26.2M.
  • Point72 (DIFC) added most to Meta Platforms (Facebook) in Q3 2025, an estimated $44.7M increase.
  • Point72 (DIFC)'s biggest Q3 2025 reduction was Analog Devices, cutting an estimated $24.4M.
  • Point72 (DIFC) fully exited NVIDIA in Q3 2025, selling an estimated $30.4M.
  • Point72 (DIFC)'s ten largest holdings make up 25% of its $1.53B portfolio in Q3 2025.
  • Point72 (DIFC) opened 503 new positions and closed 880 in Q3 2025.
  • Point72 (DIFC)'s portfolio value fell 42% quarter-over-quarter to $1.53B.

Based on Point72 (DIFC)'s 13F filing for Q3 2025, filed 14 Nov 2025.